Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Research aarkstoreenterprise disease and therapy review diabetes


Published on

  • Be the first to comment

  • Be the first to like this

Research aarkstoreenterprise disease and therapy review diabetes

  1. 1. ResearchAarkstoreEnterprise Disease and Therapy Review: Diabetes Teradata Corporation - SWOT Analysis company profile is the essentialsource for top-level company data and information. Teradata Corporation - SWOTAnalysis examines the company’s key business structure and operations, history andproducts, and provides summary analysis of its key revenue lines and strategy.Teradata Corporation (Teradata or the company) is a provider of enterprise datawarehousing, including enterprise analytic technologies and services. Its datawarehousing solutions include the database and application software, hardware platform,and related consulting and support services. The company primarily operates in the US. Itis headquartered in Dayton, Ohio, and employs about 7,400 people. The companyrecorded revenues of $1,936 million during the financial year ended December 2010(FY2010), an increase of 13.3% over 2009. The increase was primarily driven by higherproduct revenue, particularly in the Americas region. The operating profit of the companywas $415 million in FY2010, an increase of 22.8% over 2009. Its net profit was $301million in FY2010, an increase of 18.5% over 2009.Scope of the Report
  2. 2. - Provides all the crucial information on Teradata Corporation required for business andcompetitor intelligence needs- Contains a study of the major internal and external factors affecting TeradataCorporation in the form of a SWOT analysis as well as a breakdown and examination ofleading product revenue streams of Teradata Corporation-Data is supplemented with details on Teradata Corporation history, key executives,business description, locations and subsidiaries as well as a list of products and servicesand the latest available statement from Teradata CorporationReasons to Purchase- Support sales activities by understanding your customers’ businesses better- Qualify prospective partners and suppliers- Keep fully up to date on your competitors’ business structure, strategy and prospects- Obtain the most up to date company information availableTable of Contents :SWOT COMPANY PROFILE: Teradata CorporationKey Facts: Teradata CorporationCompany Overview: Teradata CorporationBusiness Description: Teradata CorporationCompany History: Teradata CorporationKey Employees: Teradata CorporationKey Employee Biographies: Teradata CorporationProducts & Services Listing: Teradata CorporationProducts & Services Analysis: Teradata CorporationSWOT analysis: Teradata Corporation*Strengths: Teradata Corporation
  3. 3. *Weaknesses: Teradata Corporation*Opportunities: Teradata Corporation*Threats: Teradata CorporationCompany View: Teradata CorporationTop Competitors: Teradata CorporationLocation and Subsidiary: Teradata Corporation*Head Office: Teradata Corporation*Other Locations and Subsidiaries: Teradata CorporationFor more information please visit link: EnterprisePhone:08149852585Email:enquiry@aarkstore.comURL:www.aarkstore.com Disease and Therapy Review: ESRD Disease and Therapy Review: Alzheimer Disease Disease and Therapy Review: Migraine Disease and Therapy Review: Stroke Disease and Therapy Review: Rheumatoid Arthritis Disease and Therapy Review: Obesity Disease and Therapy Review:Major Depressive Disorder Disease and Therapy Review: HIV/AIDS Disease and Therapy Review: Epilepsy Disease and Therapy Review: Parkinsons Disease
  4. 4. Disease and Therapy Review: Heart FailureDisease and Therapy Review: Hepatitis CDisease and Therapy Review: Bipolar DisorderDisease and Therapy Review: Breast CancerAsthma – Executive Market Summary 2011Bladder Cancer – Executive Market Summary 2011Colorectal Cancer – Executive Market Summary 2011Chronic Obstructive Pulmonary Disease (COPD) – Executive Market Summary 2011Onychomycosis – Executive Market Summary 2011Ulcerative Colitis – Executive Market Summary 2011Impetigo – Executive Market Summary 2011